Elite Pharmaceuticals, Inc. Watch

from NT 10-K ~5 pages Exhibit 1 Elite Pharmaceuticals, Inc. and Subsidiary Consolidated Statements of Operations

from 8-A12G 57 pages Rights Agreement by and Between Elite Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC as Rights Agent Dated as of November 15, 2013

from SC 13D/A 1 page Exhibit 1 Joint Filing Agreement the Undersigned Hereby Agree to Make Joint Filings of Form 13d With the U.S. Securities and Exchange Commission With Respect to Their Beneficial Ownership of the Common Stock, Par Value $0.01 Per Share, of Elite Pharmaceuticals, Inc., a Delaware Corporation, Including All Amendments Thereto. Date: December 16, 2002 /S/ John A. Moore John A. Moore /S/ Hilary Edson Hilary Edson Edson Moore Corp. By: /S/ John A. Moore Name: John A. Moore Title: Chief Executive Officer